Joakim Wijkstrom's most recent trade in Vanda Pharmaceuticals Inc was a trade of 15,520 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 15,520 | 239,269 (0%) | 0% | 4.8 | 73,875 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 254,789 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 4.21 per share. | 04 Mar 2024 | 9,229 | 129,789 (0%) | 0% | 4.2 | 38,830 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 04 Mar 2024 | 7,498 | 139,018 (0%) | 0% | 4.4 | 33,091 | Common Stock |
| Vanda Pharmaceuticals Inc | Wijkstrom Joakim | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 32,700 | 146,516 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 21 Aug 2023 | 3,724 | 113,816 (0%) | 0% | 5.8 | 21,748 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 02 Mar 2023 | 7,720 | 121,653 (0%) | 0% | 6.2 | 48,123 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 6.32 per share. | 02 Mar 2023 | 4,113 | 117,540 (0%) | 0% | 6.3 | 25,994 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 129,373 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 10.27 per share. | 22 Aug 2022 | 3,605 | 96,673 (0%) | 0% | 10.3 | 37,007 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 107,252 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 6,974 | 100,278 (0%) | 0% | 11.2 | 78,060 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 20 Aug 2021 | 3,650 | 74,552 (0%) | 0% | 15.4 | 56,190 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 18.45 per share. | 02 Mar 2021 | 3,888 | 78,202 (0%) | 0% | 18.4 | 71,729 | Common Stock |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 61,200 | 61,200 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,800 | 82,090 (0%) | 0% | - | Common Stock | |
| Vanda Pharmaceuticals Inc | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 11.08 per share. | 20 Aug 2020 | 3,710 | 56,290 (0%) | 0% | 11.1 | 41,109 | Common Stock |